Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment
Øystein Fluge, Kristin Risa, Sigrid Lunde, et al.
PLoS ONE (2015) Vol. 10, Iss. 7, pp. e0129898-e0129898
Open Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
Santa Rasa, Zaiga Nora-Krūkle, Nina Henning, et al.
Journal of Translational Medicine (2018) Vol. 16, Iss. 1
Open Access | Times Cited: 265
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Evidence for an autoimmune disease
Franziska Sotzny, Julià Blanco, Enrica Capelli, et al.
Autoimmunity Reviews (2018) Vol. 17, Iss. 6, pp. 601-609
Open Access | Times Cited: 237
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review
Mateo Cortes Rivera, Claudio A. Mastronardi, Claudia Silva, et al.
Diagnostics (2019) Vol. 9, Iss. 3, pp. 91-91
Open Access | Times Cited: 228
Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome
Madlen Loebel, Patricia Grabowski, Harald Heidecke, et al.
Brain Behavior and Immunity (2015) Vol. 52, pp. 32-39
Open Access | Times Cited: 212
The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection
Narges Moghimi, Mario Di Napoli, José Biller, et al.
Current Neurology and Neuroscience Reports (2021) Vol. 21, Iss. 9
Open Access | Times Cited: 174
Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome
Øystein Fluge, Olav Mella, Ove Bruland, et al.
JCI Insight (2016) Vol. 1, Iss. 21
Open Access | Times Cited: 169
Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity
Franziska Sotzny, Igor Salerno Filgueiras, Claudia Kedor, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 74
Treatment of primary Sjögren’s syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity
Thomas Dörner, Maximilian Posch, Yue Li, et al.
Annals of the Rheumatic Diseases (2019) Vol. 78, Iss. 5, pp. 641-647
Closed Access | Times Cited: 141
Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome
Jesús Castro‐Marrero, Naia Sáez‐Francàs, Dafna Santillo, et al.
British Journal of Pharmacology (2017) Vol. 174, Iss. 5, pp. 345-369
Open Access | Times Cited: 116
Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model
Jonas Blomberg, Carl‐Gerhard Gottfries, Amal Elfaitouri, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 109
Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME
Carmen Scheibenbogen, Madlen Loebel, Helma Freitag, et al.
PLoS ONE (2018) Vol. 13, Iss. 3, pp. e0193672-e0193672
Open Access | Times Cited: 97
Pathological Mechanisms Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Daniel Missailidis, Sarah J. Annesley, Paul R. Fisher
Diagnostics (2019) Vol. 9, Iss. 3, pp. 80-80
Open Access | Times Cited: 76
Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis?
Stefan R. Bornstein, Karin Voit-Bak, Timo Donate, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 34-37
Open Access | Times Cited: 75
Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome
Manuel Ruiz-Pablos, Bruno Paiva, Rosario Montero-Mateo, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 71
Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS
Bianka Jäkel, Claudia Kedor, Patricia Grabowski, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 61
Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Helma Freitag, Marvin Szklarski, S. Lorenz, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 16, pp. 3675-3675
Open Access | Times Cited: 58
Autoimmune autonomic nervous system imbalance and conditions: Chronic fatigue syndrome, fibromyalgia, silicone breast implants, COVID and post-COVID syndrome, sick building syndrome, post-orthostatic tachycardia syndrome, autoimmune diseases and autoimmune/inflammatory syndrome induced by adjuvants
Анна Малкова, Yehuda Shoenfeld
Autoimmunity Reviews (2022) Vol. 22, Iss. 1, pp. 103230-103230
Closed Access | Times Cited: 45
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium
Otávio Cabral-Marques, Guido Moll, Rusan Catar, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 5, pp. 103310-103310
Closed Access | Times Cited: 34
Fighting Post-COVID and ME/CFS – development of curative therapies
Carmen Scheibenbogen, Judith Bellmann‐Strobl, Cornelia Heindrich, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 33
Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis
Martin Achleitner, Charlotte Steenblock, Juliane Dänhardt, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 7, pp. 2872-2877
Open Access | Times Cited: 27
Endothelial dysfunction in ME/CFS patients
Miriam Kristine Sandvik, Kari Sørland, Elisabeth Leirgul, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0280942-e0280942
Open Access | Times Cited: 26
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease
Hayley Arron, Benjamin D. Marsh, Douglas B. Kell, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Advancing Research and Treatment: An Overview of Clinical Trials in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Future Perspectives
Katharine A. Seton, José Espejo, Karen Giménez-Orenga, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 325-325
Open Access | Times Cited: 9
Postural Orthostatic Tachycardia Syndrome: Prevalence, Pathophysiology, and Management
Adena Zadourian, Taylor A. Doherty, Iwona Świątkiewicz, et al.
Drugs (2018) Vol. 78, Iss. 10, pp. 983-994
Closed Access | Times Cited: 79
B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Øystein Fluge, Ingrid G. Rekeland, Katarina Lien, et al.
Annals of Internal Medicine (2019) Vol. 170, Iss. 9, pp. 585-585
Closed Access | Times Cited: 69
Page 1 - Next Page

Scroll to top